Citius Oncology, Inc. (CTOR)

1.13 0.00 (0.00%) USD  |  NASDAQ  |  Dec 12, 16:00
1.12 -0.01 (-0.88%) After-Hours: 20:00
More

Citius Oncology Research and Development Expense (TTM)

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for CTOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Citius Pharmaceuticals, Inc. 10.43M
Amicus Therapeutics, Inc. 142.29M
Soligenix, Inc. 8.144M
Tonix Pharmaceuticals Holding Corp. 35.84M
GT Biopharma, Inc. 4.026M